Caution Required in the Use of Administrative Data and General Laboratory Submissions for Influenza Vaccine Effectiveness Estimation

Danuta M Skowronski; Gaston De Serres; Walter Orenstein

About this item:

152 Views | 90 Downloads

Author Notes:

Z. Zong, Center of Infectious Diseases, West China Hospital (Huaxi), Guoxuexiang 37, Chengdu 610041, China (zongzhiy@scu.edu.cn).

D. M. S. has received grants from the Public Health Agency of Canada for influenza vaccine effectiveness estimation.

G. D. S. has received grants from Pfizer for investigator-initiated studies unrelated to influenza vaccine and provided paid expert testimony for the Ontario Nurses Association, the Quebec Ministry of Justice, and GlaxoSmithKline.

Subjects:

Keywords:

Science & Technology
Life Sciences & Biomedicine
Immunology
Infectious Diseases
Microbiology

Caution Required in the Use of Administrative Data and General Laboratory Submissions for Influenza Vaccine Effectiveness Estimation

Danuta M Skowronski, British Columbia Center for Disease Control

Gaston De Serres, Institut National de Santé Publique du Québec

Walter Orenstein, Emory University

Tools:

Journal Title:

Clinical Infectious Diseases

Volume:

Volume 69, Number 6

Publisher:

Oxford University Press (OUP): Policy B - Oxford Open Option C | 2019-09-15, Pages 1084-1085

Type of Work:

Article | Final Publisher PDF

Permanent URL:

https://pid.emory.edu/ark:/25593/v763c

Publisher DOI:

http://doi.org/10.1093/cid/ciz113

Copyright information:

Export to EndNote

Undergraduate

Community

Graduate

Libraries

Library Tools

Resources

Resources

About this item:

Author Notes:

Subjects:

Keywords:

Caution Required in the Use of Administrative Data and General Laboratory Submissions for Influenza Vaccine Effectiveness Estimation

Tools:

Copyright information: